跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CLINIMIX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CLINIMIX
Authorized
STANDARD
CLINIMIX
baxter corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5f75bd917b6665a6
Company
baxter corporation
Type
Standard
Approval Details
Approval Id
5f75bd917b6665a6
Drug Approval Canada Name
CLINIMIX
Product Name
CLINIMIX
Status
Marketed
Status Date
2023-04-26
Original Market Date
2023-04-26
Din
02498456
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:20.00
Atc Original
B05BA10 COMBINATIONS
Atc Name
b 05 ba 10
Aig Number
1662220002
Company Name
baxter corporation
Company Address
7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2
Active Ingredients
ALANINE
1656 MG / 100 ML
GLYCINE
824 MG / 100 ML
HISTIDINE
384 MG / 100 ML
DEXTROSE
10 G / 100 ML
L-ARGININE
920 MG / 100 ML
L-ISOLEUCINE
480 MG / 100 ML
L-LEUCINE
584 MG / 100 ML
L-LYSINE HYDROCHLORIDE
464 MG / 100 ML
L-PHENYLALANINE
448 MG / 100 ML
L-PROLINE
544 MG / 100 ML
L-THREONINE
336 MG / 100 ML
METHIONINE
320 MG / 100 ML
SERINE
400 MG / 100 ML
L-TYROSINE
32 MG / 100 ML
L-VALINE
464 MG / 100 ML
TRYPTOPHAN
144 MG / 100 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5f75bd917b6665a6
Type
Standard
Back to Health Canada Approvals